Kaleido Biosciences to Present at the Keystone Symposium "Harnessing the Microbiome for Disease Prevention and Therapy" Conference
Kaleido Biosciences to Present at the Keystone Symposium “Harnessing the Microbiome for Disease Prevention and Therapy” Conference LEXINGTON, Mass., Jan. 20, 2021 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), today announced Johan van Hylckama Vlieg, Ph.D., Chief Scientific Officer, will present at the Keystone Symposium “Harnessing the Microbiome for Disease Prevention and Therapy” conference this afternoon at 12:15 p.m. MST. The presentation will provide an update on progress with the Kaleido MMT TM platform, including a review of the K031 COVID-19 study interim dat...
Source: forextv.com
